Harm reduction measures and antiretroviral therapy are cutting down B.C.’s HIV infection rates among injection drug users, says a new report released Thursday by the Ministry of Health Services.
A new report says there are fewer new cases of HIV among injection drug users in B.C., and health officials are crediting the province's harm reduction programs.
B.C.'s top doctor is pushing to keep harm reduction and antiretroviral therapy as key health strategies after a new report showed rates of HIV infection among those who inject drugs continues to drop.
BC-CfE director Dr. Julio Montaner discusses the fight to control the HIV/AIDS in the Downtown Eastside and how Canada and the global community must refocus on HIV treatment before the crisis spirals out of control.
The New York Times examines Vancouver's success in curbing new HIV infections through harm reduction and the BC-CfE's pioneering "treatment as prevention" strategy.
Northern Health is one of two health authorities implementing the STOP HIV/AIDS pilot project, a four-year initiative to improve access to HIV testing, treatment, and support services in British Columbia.
After major breakthroughs that have twice changed the worldwide norm of AIDS therapy within the past 15 years, the BC-CfE is taking the fight against the disease to a new level.
A comprehensive economic evaluation of the net benefit of HAART in B.C. by BC-CfE researchers makes a compelling case that wider use of HAART can curb the spread of the HIV epidemic and save hundreds of millions of dollars in health care costs.
The benefits of HAART extend beyond treatment of the virus to significantly preventing the transmission and spread of HIV, according to new BC-CfE research.
New HIV diagnoses dropped by more than half since the introduction of highly active antiretroviral therapy (HAART) for HIV-infected patients, a BC-CfE study shows, suggesting that the treatment was effective at reducing viral load.
BC-CfE researchers have become the first in the world to confirm that an aggressive treatment for HIV significantly cuts the number of people contracting the virus that causes AIDS.
The importance of treating people with HIV with antiretroviral drugs is greater than ever, BC-CfE researchers say, after they discovered a significant drop in new HIV diagnoses when more people were treated with the drug cocktails.
Dr. Julio Montaner, director of the BC-CfE and president of the International AIDS Society, spoke to The Globe and Mail’s André Picard about his hopes and expectations going into the 18th International AIDS Conference, which opened Sunday in Vienna.
A new study by BC-CfE researchers that shows a substantial drop in HIV transmission has triggered a dramatic shift in UNAIDS treatment strategy.Toronto Star - New hope to halt spread of HIV
The world's experts in HIV and AIDS have gathered in Vienna this week and Vancouver is represented by a team of doctors and activists, including Dr. Julio Montaner, the director of the BC Centre for Excellence in HIV/AIDS.
Groundbreaking new research from the BC-CfE shows that treating people with the AIDS virus can provide a powerful bonus: It cuts the risk that they will infect others.
World leaders lack the political will to ensure that everyone infected with HIV and AIDS gets treatment, BC-CfE director and AIDS 2010 chair Dr. Julio Montaner said Sunday.
The introduction of antiretroviral therapy has not only transformed HIV from a virtual death sentence into a manageable disease, but treatment also appears to slash the number of new infections, BC-CfE researchers say.
Treating HIV patients with cocktails of AIDS drugs helps to stop them spreading the infection further and more than halved the number of new HIV diagnoses, BC-CfE researchers said Sunday.
Copyright BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital 608 - 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6 General Telephone: 604-806-8477 | Fax: 604-806-9044 Email: info@cfenet.ubc.ca